10th AMIT International Congress, Milan - March 27th-28th, 2025
Seguici anche su: Facebook Linkedin Twitter
MyConference
Register now!
Login
10th AMIT INTERNATIONAL CONGRESS

10th AMIT

INTERNATIONAL CONGRESS

Topics in Infectious and Tropical Diseases

March 27th-28th, 2025
Castiglioni Palace
Corso Venezia 47
Milan - Italy

AMIT

Program | 10th AMIT INTERNATIONAL CONGRESS, Milan - March 27th-28th, 2025

Il programma scirntifico dell'evento

Program
08.45-09.00
Opening remarks
A. Castagna, M. Tinelli
09.00-09.30
Opening Lecture
New anti-infective drugs: EMA ongoing marketing authorisation
M. Cavaleri
SESSION 1
MDR epidemiology and antimicrobial resistance control plan in Italy
Chairs: P. Bonfanti, W. Marrocco
09.30-09.50
Update of epidemiology of multidrug resistance microorganisms in Italy
F. D’Ancona
09.50-10.10
The ongoing Italian plan of antimicrobial resistance control
F. Maraglino
10.10-10.20
Discussion
10.20-11.10
Round Table
Chairs: C. Mussini, R. Parrella
 
Doctor or robot? The prospects of artificial intelligence in infectious diseases
F. Consolo, S. Merler, R. Murri
SESSION 2
Update of treatment strategies in bacterial and fungal infections
Chairs: M. Bartoletti, C.M. Mastroianni
11.10-11.30
Place in therapy of antibiotics to treat MDR infections
P. Viale
11.30-11.50
Optimizing antibiotic therapy in intensive care unit
M. Falcone
11.50-12.10
Current and future therapeutic options in invasive mycosis
M. Bassetti
12.10-12.20
Discussion
SESSION 3
HIV from prevention to cure
Chairs: A. Cattelan, A. Gori
12.20-12.40
The role of broadly neutralizing antibodies in HIV cure
S.G. Deeks
12.40-13.00
Pre-exposure prophylaxis in Italy: where are we?
A. Antinori
13.00-13.20
Present and future of HIV treatment
A. Castagna
13.20-13.30
Discussion
13.30-14.30
Poster Session Displayed and on site during the lunch
13.30-14.30
Lunch
SESSION 4
Policy strategies to tackle infectious diseases: looking to the future
Chairs: F. Castelli, M. Puoti
14.30-14.50
Arbovirosis: vaccination strategies
E. Nicastri
14.50-15.10
HBV/HDV: current and new antiviral treatments
P. Lampertico
15.10-15.30
The added value of monoclonal antibodies in infectious diseases
E. Andreano
15.30-15.40
Discussion
SESSION 5
Long-acting drugs: challenges and opportunities in real-life
Chairs: D. Cattaneo, G. Cenderello
15.40-16.00
In bacterial infections
C. Tascini
16.00-16.20
In fungal infections
A. Mularoni
16.20-16.40
In viral infections
C. Muccini
16.40-16.50
Discussion
09.00-09.30
Opening Lecture
Chairs: M. Andreoni
 
Key variables in clinical research to assess efficacy of phage therapy
J.P. Pirnay
SESSION 6
UpToDate of infectious diseases management
Chairs: M. Crapis, G.C. Marchetti
09.30-09.50
Combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection
G. Tiseo
09.50-10.10
Cardiovascular infections and indication for urgent cardiac surgery
E. Durante Mangoni
10.10-10.30
From bedside to doorstep: the shift towards home management of infectious diseases
M. Ripa
10.30-10.50
UpToDate in anaerobic bacterial infections
D.R. Giacobbe
10.50-11.00
Discussion
SESSION 7
Emerging infectious diseases and environmental health
Chairs: S. Antinori, M. Sabbatucci
11.00-11.20
Preparedness for pandemics and emerging infectious disease threats
S. Brusaferro
11.20-11.40
Antibiotic use in animal feed and its impact on human health
L. Candela
11.40-12.00
Antibiotic resistance and environmental health
M. Tinelli
12.00-12.10
Discussion
SESSION 8
Antibiotic stewardship and infection control
Chairs: A. Bandera, S. Piconi
12.10-12.30
How to implement an AMS program in your hospitals
J. Schouten
12.30-12.50
Prevention and management of infections in global surgery
M. Sartelli
12.50-13.10
Best practice in vascular access and infusion therapy: state of the art
M. Pittiruti
13.10-13.20
Discussion
13.20-14.20
Poster Session Displayed and on site during the lunch
13.20-14.20
Lunch
SESSION 9
Meeting Young Experts in Infectious Diseases
Chairs: A. Castagna, F. Menichetti
14.20-14.35
Case report: MDR patient’s colonization
M. Meschiari
14.35-14.50
Case report: PWH with limited treatment options
V. Spagnuolo
14.50-15.05
Case report: Invasive mycosis in hematologic patients
L. Bussini
15.05-15.20
Case report: Impact of antibiotics on gut microbioma
C. Tincati
15.20-15.30
Discussion
SESSION 10
Infectious diseases: when the host matters
Chairs: A. Davì, P. Giuri
15.30-15.50
UpToDate of antibiotic treatment in pediatrics
E. Castagnola
15.50-16.10
Risks factors of infectious in plastic and aesthetic surgery
V. Vinci
16.10-16.30
STIs and resistance
S. Nozza
16.30-16.40
Discussion
16.40-17.00
Conclusive remarks
A. Castagna, M. Tinelli
×
Icon